Biosolution Co.Ltd
Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2… Read more
Biosolution Co.Ltd (086820) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.001x
Based on the latest financial reports, Biosolution Co.Ltd (086820) has a cash flow conversion efficiency ratio of 0.001x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩17.41 Million) by net assets (₩26.31 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biosolution Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Biosolution Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biosolution Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biosolution Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
First Farmers and Merchants Corporation
PINK:FFMH
|
0.021x |
|
First Steamship Co Ltd
TW:2601
|
0.018x |
|
Tjk Machinery Tianjin Co Ltd
SHE:300823
|
0.043x |
|
Firstec
KO:010820
|
-0.196x |
|
Bally's Corp
NYSE:BALY
|
-0.170x |
|
AFTERMATH SILVER
F:FLM1
|
N/A |
|
QuickLogic Corporation
NASDAQ:QUIK
|
0.006x |
|
Wave Cyber Shanghai Co Ltd
SHG:688718
|
0.028x |
Annual Cash Flow Conversion Efficiency for Biosolution Co.Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Biosolution Co.Ltd from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩31.26 Billion | ₩-2.29 Billion | -0.073x | -242.66% |
| 2023-12-31 | ₩42.13 Billion | ₩2.16 Billion | 0.051x | +158.85% |
| 2022-12-31 | ₩43.78 Billion | ₩-3.81 Billion | -0.087x | -4808.31% |
| 2021-12-31 | ₩45.01 Billion | ₩83.29 Million | 0.002x | +105.12% |
| 2020-12-31 | ₩46.66 Billion | ₩-1.69 Billion | -0.036x | +33.31% |
| 2019-12-31 | ₩48.10 Billion | ₩-2.61 Billion | -0.054x | -359.07% |
| 2018-12-31 | ₩49.06 Billion | ₩1.03 Billion | 0.021x | +217.65% |
| 2017-12-31 | ₩4.42 Billion | ₩-78.53 Million | -0.018x | +94.74% |
| 2016-12-31 | ₩6.12 Billion | ₩-2.07 Billion | -0.338x | -24.26% |
| 2015-12-31 | ₩7.40 Billion | ₩-2.02 Billion | -0.272x | -- |